Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Shingles - How up-to-date is this topic?
Changes

Version 1.3, revision planned in 2012.

Last revised in August 2008

September 2010 — the choice of drug treatment for neuropathic pain has been updated in line with the NICE clinical guideline, Neuropathic pain. The pharmacological management of neuropathic pain in adults in non-specialist settings [NICE, 2010]. Issued in September 2010.

April to June 2010 — updated. The section on management of shingles in immunocompromised people has been updated to clarify that oral antiviral treatment can be considered in primary care if the rash is localized and the person is not systemically unwell or severely immunocompromised. Issued in June 2010.

March 2009 — minor update to include a link to the CKS topic on Neuropathic pain - drug treatment. Issued in April 2009.

May to August 2008 — converted from PRODIGY guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence.

This topic previously incorporated the management of post-herpetic neuralgia, for which a separate CKS topic is now available. There have been minor changes to the recommendations regarding antiviral treatment.

© NHS Institute for Innovation and Improvement